Professor Olivier Michielin Discusses mRNA Advances in Le Temps

Patrycja Nowak-Sliwinska was awarded the prestigious European Certified Pharmacologist (EuCP) designation

Denis Migliorini has been promoted to Associate Professor

Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors

Revolutionising oncology through precision medicine

Camilla Jandus: "Our immune defences are still far from having revealed all their secrets"

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer

Immune 'hijacking' predicts cancer evolution

The promises of AI in terms of cancer treatment

Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial

Pfizer Prize for a personalised therapeutic vaccine against cancer

Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state